syrisal 292.5mg/5ml (1mmol/ml) oral solution
1mmol/ml) oral solution (thame laboratories ltd - sodium chloride - oral solution - 58.5mg/1ml
phospho-soda oral solution bottle
chiesi australia pty ltd - dibasic sodium phosphate, quantity: 4.3 g; monobasic sodium phosphate, quantity: 18.8 g - oral liquid - excipient ingredients: glycerol; saccharin sodium; sodium benzoate; purified water; flavour - for use as part of a bowel cleansing regimen in preparing adult patients for colon surgery or for preparing the colon for x-ray or endoscopic examination.
allmercap mercaptopurine monohydrate 20mg/ml oral liquid suspension bottle
link medical products pty ltd t/a link pharmaceuticals - mercaptopurine monohydrate, quantity: 20 mg/ml - oral liquid, suspension - excipient ingredients: xanthan gum; aspartame; rubus idaeus; sodium methyl hydroxybenzoate; sodium ethyl hydroxybenzoate; potassium sorbate; sodium hydroxide; purified water - allmercap oral liquid suspension is indicated for: treatment of acute lymphoblastic leukaemia (all) in paediatric patients.
amcal nystatin oral drops nystatin 100,000iu/ml oral solution bottle
cipla australia pty ltd - nystatin, quantity: 100000 iu/ml - oral liquid - excipient ingredients: sodium citrate dihydrate; sucrose; sodium hydroxide; carmellose sodium; propyl hydroxybenzoate; saccharin sodium; purified water; methyl hydroxybenzoate; flavour - for the treatment of oral candidal infections only
mycostatin oral drops nystatin 100000 iu/ml oral liquid suspension bottle
aspen pharmacare australia pty ltd - nystatin, quantity: 100000 iu/ml - oral liquid, suspension - excipient ingredients: propyl hydroxybenzoate; sodium calcium edetate; polysorbate 80; purified water; quinoline yellow; methyl hydroxybenzoate; sucrose; hydrochloric acid; bentonite; flavour - infections of the oral cavity caused by candida albicans.
phenoxymethylpenicillin-aft phenoxymethylpenicillin (as potassium salt) 250mg/5ml powder for oral liquid bottle
aft pharmaceuticals pty ltd - phenoxymethylpenicillin potassium, quantity: 56.568 mg/ml (equivalent: phenoxymethylpenicillin, qty 50 mg/ml) - oral liquid, powder for - excipient ingredients: sucrose; sodium benzoate; saccharin sodium; flavour; colour - when oral therapy is required in the treatment of mild to moderately severe infections due to penicillin sensitive organisms such as penicillin sensitive staphylococci, pneumococci, gonococci and haemolytic streptococci. therapy should be guided by bacteriological studies, including sensitivity tests, and by clinical response. for prophylactic use in recurrent streptococcal infections including the prevention of recurrence following rheumatic fever and/or sydenham's chorea. for the prevention of bacterial endocarditis in patients with rheumatic fever and/or congenital heart disease who are about to undergo dental or upper respiratory surgery or instrumentation. oral penicillin should not be used as adjunctive prophylaxis for genitourinary instrumentation or surgery, lower intestinal tract surgery, sigmoidoscopy or complications of childbirth.
phenoxymethylpenicillin-aft phenoxymethylpenicillin (as potassium salt) 125mg/5ml powder for oral liquid bottle
aft pharmaceuticals pty ltd - phenoxymethylpenicillin potassium, quantity: 28.284 mg/ml (equivalent: phenoxymethylpenicillin, qty 25 mg/ml) - oral liquid, powder for - excipient ingredients: sucrose; sodium benzoate; saccharin sodium; colour; flavour - when oral therapy is required in the treatment of mild to moderately severe infections due to penicillin sensitive organisms such as penicillin sensitive staphylococci, pneumococci, gonococci and haemolytic streptococci. therapy should be guided by bacteriological studies, including sensitivity tests, and by clinical response. for prophylactic use in recurrent streptococcal infections including the prevention of recurrence following rheumatic fever and/or sydenham's chorea. for the prevention of bacterial endocarditis in patients with rheumatic fever and/or congenital heart disease who are about to undergo dental or upper respiratory surgery or instrumentation. oral penicillin should not be used as adjunctive prophylaxis for genitourinary instrumentation or surgery, lower intestinal tract surgery, sigmoidoscopy or complications of childbirth.
cilicaine v phenoxymethylpenicillin (as benzathine) 150mg/5ml oral liquid, suspension bottle
viatris pty ltd - phenoxymethylpenicillin benzathine, quantity: 40.27 mg/ml (equivalent: phenoxymethylpenicillin, qty 30 mg/ml) - oral liquid, suspension - excipient ingredients: sodium propyl hydroxybenzoate; sodium methyl hydroxybenzoate; butylated hydroxyanisole; polysorbate 80; xanthan gum; sucrose; purified water; sodium citrate dihydrate; potassium sorbate; citric acid; flavour - treatment of mild to moderately severe infections due to penicillin sensitive staphylococci, pneumococci, gonococci and haemolytic streptococci infections. therapy should be guided by bacteriological studies, including sensitivity tests, and by clinical response. for prophylactic use in recurrent streptococcal infections including the prevention of recurrence following rheumatic fever and/or sydenham's chorea and to prevent bacterial endocarditis in patients with rheumatic fever and/or congenital heart disease who are about to undergo dental or upper respiratory surgery or instrumentation. note: oral penicillin should not be used as adjunctive prophylaxis for genitourinary instrumentation or surgery, lower intestinal tract surgery, sigmoidoscopy or complications of childbirth.
acidex oral suspension peppermint
pinewood healthcare - sodium alginate; calcium carbonate; sodium bicarbonate - oral suspension - 50mg/1ml ; 16mg/1ml ; 26.7mg/1ml
exelon rivastigmine (as hydrogen tartrate) 2mg/ml oral solution bottle
novartis pharmaceuticals australia pty ltd - rivastigmine hydrogen tartrate, quantity: 3.2 mg/ml (equivalent: rivastigmine, qty 2 mg/ml) - oral liquid, solution - excipient ingredients: citric acid; sodium citrate dihydrate; purified water; sodium benzoate; quinoline yellow - exelon is indicated for the treatment of patients with mild to moderately severe dementia of the alzheimer's type.